Your browser doesn't support javascript.
loading
Adjuvant chemotherapy and relative survival of patients with stage II colon cancer - A EURECCA international comparison between the Netherlands, Denmark, Sweden, England, Ireland, Belgium, and Lithuania.
Breugom, A J; Bastiaannet, E; Boelens, P G; Iversen, L H; Martling, A; Johansson, R; Evans, T; Lawton, S; O'Brien, K M; Van Eycken, E; Janciauskiene, R; Liefers, G J; Cervantes, A; Lemmens, V E P P; van de Velde, C J H.
Afiliação
  • Breugom AJ; Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands.
  • Bastiaannet E; Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands; Department of Gerontology and Geriatrics, Leiden University Medical Center, Leiden, The Netherlands.
  • Boelens PG; Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands.
  • Iversen LH; Department of Surgery, Aarhus University Hospital, Aarhus, Denmark.
  • Martling A; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
  • Johansson R; Department of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden.
  • Evans T; Public Health England, Birmingham, United Kingdom.
  • Lawton S; Public Health England, York, United Kingdom.
  • O'Brien KM; National Cancer Registry Ireland, Cork, Ireland.
  • Van Eycken E; Belgian Cancer Registry, Brussels, Belgium.
  • Janciauskiene R; Oncology Institute of Lithuanian University of Health Sciences, Kaunas, Lithuania.
  • Liefers GJ; Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands.
  • Cervantes A; Department of Haematology and Medical Oncology, Institute of Health Research INCLIVA, University of Valencia, Valencia, Spain.
  • Lemmens VE; Department of Research, Netherlands Comprehensive Cancer Organisation (IKNL), Eindhoven, The Netherlands; Department of Public Health, Erasmus MC University Medical Centre, Rotterdam, The Netherlands.
  • van de Velde CJ; Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands. Electronic address: C.J.H.van_de_Velde@lumc.nl.
Eur J Cancer ; 63: 110-7, 2016 08.
Article em En | MEDLINE | ID: mdl-27299663
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias do Colo Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Eur J Cancer Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Holanda
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias do Colo Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Eur J Cancer Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Holanda